Abstract

The CFAR Developmental Core is a major route by which the CFAR acts as a catalyst for AIDS research at NYU. The goals of the Developmental Core are to encourage new investigators and innovation, and to permit a rapid response to new research opportunities. A major portion of the developmental funds of $200,000 per year is used to fund pilot projects proposed by young investigators or investigators who are new to the area of AIDS-related research. These awards are made after a thorough evaluation and discussion of all submitted applications by our Scientific Review Committee, followed by a secret ballot. An amount of up to $50,000 is awarded to recipients. If promising results have been obtained at the end of the first year, and if a strong case can be made for additional benefit, and if an outside application for funding has been submitted, the Committee has sometimes agreed to provide an additional $50,000 for a second year. This can increase the ability to complete a project successfully. Two additional categories of investigation may be supported by developmental funds: A rapid response to new research opportunities, which must involve a collaborative effort, and the development of new technologies.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027742-20
Application #
7935349
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
2012-06-30
Budget Start
2009-07-01
Budget End
2012-06-30
Support Year
20
Fiscal Year
2009
Total Cost
$500,665
Indirect Cost

  Institution

Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016

  Publications

Gornalusse, German G; Mummidi, Srinivas; Gaitan, Alvaro A et al. (2015) Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor. Proc Natl Acad Sci U S A 112:E4762-71
Miller, Elizabeth A; Gopal, Ramya; Valdes, Vanessa et al. (2015) Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection. AIDS 29:1287-96
Weiden, Michael D; Hoshino, Satomi; Levy, David N et al. (2014) Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages. PLoS One 9:e108476
Ryndak, Michelle B; Singh, Krishna K; Peng, Zhengyu et al. (2014) Transcriptional profiling of Mycobacterium tuberculosis replicating ex vivo in blood from HIV- and HIV+ subjects. PLoS One 9:e94939
Phelan, Joan A; Abrams, William R; Norman, Robert G et al. (2014) Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes. PLoS One 9:e112901
Sivapalasingam, Sumathi; Mendillo, Megan; Ahmed, Aabid et al. (2014) The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya. AIDS Care 26:425-33
Weiser, Keren; Barton, Meredith; Gershoony, Dafna et al. (2013) HIV's Nef interacts with ?-catenin of the Wnt signaling pathway in HEK293 cells. PLoS One 8:e77865
O'Brien, Meagan; Montenont, Emilie; Hu, Liang et al. (2013) Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. J Acquir Immune Defic Syndr 63:280-8
Rich, Josiah D; DiClemente, Ralph; Levy, Judith et al. (2013) Correctional facilities as partners in reducing HIV disparities. J Acquir Immune Defic Syndr 63 Suppl 1:S49-53
Alvarez, Yelina; Tuen, Michael; Nàdas, Arthur et al. (2012) In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines. AIDS Res Hum Retroviruses 28:823-34

Showing the most recent 10 out of 254 publications